from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2375/-

LFCtreatmentdescriptionclass of inhibitor

1.142

Amikacinug/mL Amikacintranslation

0.756

Cap5-10ug/mL Capreomycintranslation

0.991

Rox10-50 ug/mL Roxithromycintranslation

0.597

SM2-5 ug/mL Streptomycintranslation

0.923

Tet5-10 ug/mL Tetracyclinetranslation

0.196

Rif0.2-5ug/mL Rifampicintranscription

-0.393

Rifp0.1-0.5ug/mL Rifapentinetranscription

3.474

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.236

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.451

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.433

Clofazimine10-13 ug/mL Clofaziminerespiration

0.722

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.699

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.926

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.111

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.587

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.148

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.755

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.149

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.050

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.917

KCN5-20 ug/mL Potassium cyaniderespiration

0.523

NaN30.2-2 mM Sodium aziderespiration

0.378

Nigericin50 uM Nigericinrespiration

-0.837

TRC10-150 ug/mL Triclosanrespiration

0.562

TRZ10-25 ug/mL Thioridazinerespiration

-0.656

Valinomycin0.5-10 uM Valinomycinrespiration

0.372

ZnSO42 mM ZnSO4respiration

0.870

menadione6-10 ug/mL Menadionerespiration

0.539

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.028

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.367

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.551

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.390

NRP_1Non-replicating persistence stage 1dosRassociated

0.352

Amp0.2mg/mL AmpicillincellWall

0.166

Cephalexin20-100 ug/mL CephalexincellWall

0.387

Cerulenin0.32-5 ug/mL CerulenincellWall

1.073

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.651

EMB10-20 ug/mL EthambutolcellWall

0.003

Eta12-40 ug/mL EthionamidecellWall

0.174

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.008

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.886

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.824

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.755

BZA0.12 mg/mL BenzamidearomaticAmides

-1.480

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.047

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.764

H2O24 mM hydrogen peroxideDNAdamaging

-0.114

Levo10 ug/mL LevofloxacinDNAdamaging

-0.459

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.265

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.246

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.087

UVUV-irradiationDNAdamaging

-1.525

ARP41-4 ug/mL Antitubercular compound ARP4?

0.556

Antimycin12.5-50 ug/mL Antimycin A?

0.183

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.349

PA_110-50 ug/mL Antitubercular compound PA-1?

0.307

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.449

PA8240.2-2 ug/mL PA-824?

-0.340

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.444

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.344

Verapamil50 uM Verapamil?

0.419

mercaptoethanol2 mM 2-Mercaptoethanol?

0.158

methoxatin10-20 ug/mL Methoxatin?